HK1258371A1 - 止血組合物和使用止血組合物的止血方法 - Google Patents

止血組合物和使用止血組合物的止血方法

Info

Publication number
HK1258371A1
HK1258371A1 HK19100742.0A HK19100742A HK1258371A1 HK 1258371 A1 HK1258371 A1 HK 1258371A1 HK 19100742 A HK19100742 A HK 19100742A HK 1258371 A1 HK1258371 A1 HK 1258371A1
Authority
HK
Hong Kong
Prior art keywords
hemostatic
composition
hemostatic composition
hemostatic method
Prior art date
Application number
HK19100742.0A
Other languages
English (en)
Inventor
Keiji Nagano
Satoru Kobayashi
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of HK1258371A1 publication Critical patent/HK1258371A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
HK19100742.0A 2015-12-18 2019-01-16 止血組合物和使用止血組合物的止血方法 HK1258371A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015247334 2015-12-18
PCT/JP2016/087298 WO2017104723A1 (ja) 2015-12-18 2016-12-14 止血用組成物、および、止血用組成物を用いた止血方法

Publications (1)

Publication Number Publication Date
HK1258371A1 true HK1258371A1 (zh) 2019-11-08

Family

ID=59056831

Family Applications (2)

Application Number Title Priority Date Filing Date
HK19100742.0A HK1258371A1 (zh) 2015-12-18 2019-01-16 止血組合物和使用止血組合物的止血方法
HK19100746.6A HK1258374A1 (zh) 2015-12-18 2019-01-16 止血組合物和使用止血組合物的止血方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK19100746.6A HK1258374A1 (zh) 2015-12-18 2019-01-16 止血組合物和使用止血組合物的止血方法

Country Status (11)

Country Link
US (2) US11298397B2 (zh)
EP (1) EP3391897B1 (zh)
JP (1) JP6951252B2 (zh)
KR (1) KR20180102583A (zh)
CN (1) CN108697755A (zh)
AU (1) AU2016374425B2 (zh)
BR (1) BR112018012260A2 (zh)
CA (1) CA3008589C (zh)
ES (1) ES2896726T3 (zh)
HK (2) HK1258371A1 (zh)
WO (1) WO2017104723A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3818071A2 (en) 2018-07-03 2021-05-12 3-D Matrix, Ltd. Ionic self-assembling peptides
EP3862013A4 (en) 2018-10-05 2022-10-05 Kurume University PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF AN ULCER OR FISTULA IN THE INTESTINAL TRACT
WO2021146291A1 (en) * 2020-01-13 2021-07-22 Arch Biosurgery, Inc. Self-assembling peptide gel formulation and methods of use
CN112023113B (zh) * 2020-08-29 2021-11-30 田卫群 一种HNTs/RG5纳米复合止血粉的制备方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006014570A2 (en) 2004-07-06 2006-02-09 3D Matrix, Inc. Purified amphilic peptide compositions and uses thereof
EP1879606B1 (en) * 2005-04-25 2013-06-12 Massachusetts Institute of Technology Self-assembling peptides for promoting hemostasis
US9415084B2 (en) 2007-03-14 2016-08-16 Arch Biosurgery, Inc. Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
JPWO2010041636A1 (ja) 2008-10-06 2012-03-08 株式会社スリー・ディー・マトリックス 組織閉塞剤
JP2015142720A (ja) * 2013-12-27 2015-08-06 株式会社メニコン 止血材
EP3116551B1 (en) 2014-03-10 2022-09-07 3-D Matrix Ltd. Sterilization of peptide compositions
TWI537022B (zh) 2015-04-28 2016-06-11 國立清華大學 閉迴路腦電刺激裝置及其刺激電壓的產生方法

Also Published As

Publication number Publication date
EP3391897B1 (en) 2021-09-08
WO2017104723A1 (ja) 2017-06-22
JPWO2017104723A1 (ja) 2018-10-04
JP6951252B2 (ja) 2021-10-20
CN108697755A (zh) 2018-10-23
US20220265757A1 (en) 2022-08-25
EP3391897A1 (en) 2018-10-24
AU2016374425B2 (en) 2021-10-21
US20180360904A1 (en) 2018-12-20
CA3008589C (en) 2024-01-23
KR20180102583A (ko) 2018-09-17
AU2016374425A1 (en) 2018-06-21
ES2896726T3 (es) 2022-02-25
US11298397B2 (en) 2022-04-12
BR112018012260A2 (pt) 2018-12-04
HK1258374A1 (zh) 2019-11-08
CA3008589A1 (en) 2017-06-22
EP3391897A4 (en) 2019-08-14

Similar Documents

Publication Publication Date Title
HK1257295A1 (zh) 用於免疫腫瘤學的組合物和方法
IL258288B (en) Hair strengthening compound and hair strengthening method
HK1259277A1 (zh) 結構複合材料和方法
GB2546350B (en) Compositions and methods
SG11202003790PA (en) Composition and method
GB201718876D0 (en) Antithrombin-heparin compositions and methods
HK1245158A1 (zh) 阿吡莫德組合物及其使用方法
IL259203B (en) Hemostatic drug
GB201518379D0 (en) Analytical method and composition
HK1258374A1 (zh) 止血組合物和使用止血組合物的止血方法
GB201520255D0 (en) Composition and method
GB2550632B (en) Compositions and uses and methods relating thereto
SG11201707046XA (en) Gel composition and method for manufacturing same
GB201700116D0 (en) Method and composition
EP3349748A4 (en) COMPOSITION AND METHOD THEREFOR
GB201502983D0 (en) Composition and process
GB201509420D0 (en) Composition and method
GB201512996D0 (en) Compositions and methods
ZA201904187B (en) Method and composition
GB201703975D0 (en) Composition and methods
GB201513492D0 (en) Method and composition
GB201514413D0 (en) Compositions and methods
GB201714238D0 (en) Composition and method
IL256261B (en) Hide1 compositions and methods
GB201611189D0 (en) Method and composition